Zitro deploys 200 Mighty Hammer machines at Mexico’s PlayCity Casino

Industry

Mexico’s PlayCity Casino has added 200 machines to its entertainment offering with Zitro‘s new Mighty Hammer 4-level progressive link multi-game, the casino gaming supplier announced Monday.

This latest addition complements the “already impressive collection” of 2,700 Zitro machines available at PlayCity across the country, the company pointed out. The new game title brings “an unusual intensity to the gaming experience” depending on the bet.

Mighty Hammer features both the Link Up and Link King functions. And with three unique link bonuses, players have a higher jackpot amount depending on the bet placed. The higher the bet, the bigger the prizes and rewards.

According to José Fernando López, Director of Slots at PlayCity Casino, the addition of Mighty Hammer has been embraced with enthusiasm by PlayCity players. “The game’s impressive performance in our gaming halls is generating a lot of excitement, and its player-favorite features, reminiscent of the popular Link King, are captivating our customers,” López stated.

It is a great honor for me to continue our partnership with PlayCity, and I appreciate the opportunity to include Mighty Hammer in their entertainment offering. We share the goal of always offering the best to their players, and we are grateful that each of our releases is part of their game selection,” added Johnny Viveiros Ortiz, founder of Zitro.

This isn’t the only deal Zitro has closed in Mexico as of late. Earlier this month, the gaming provider announced that Mexican group Winpot has added more than 200 slots with the Mighty Hammer game theme to its casinos as well.

Articles You May Like

Brazilian Puts On Dazzling Performance in 888poker XL Spring Series Mystery Bounty Event
Betting on Arcade Games & Skee-Ball?
European Gaming Congress 2024 announces extended two-day agenda at Polonia Palace Hotel
Iconic Mirage Casino to Close for Hard Rock Las Vegas Transformation
2023 WSOP Winner Auctioning Bracelet to Benefit Cancer Research

Leave a Reply

Your email address will not be published. Required fields are marked *